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ABSTRACT
ANALYSIS OF FETAL GLOBIN GENE EXPRESSION IN KUWAITIS
WITH SICKLE CELL DISEASE.
HEMATOLOGY,

ANN V. ARTHUR, SECTION OF

DEPARTMENT OF INTERNAL MEDICINE, YALE

UNIVERSITY SCHOOL OF MEDICINE, NEW HAVEN, CONNECTICUT.
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A clinically mild form of sickle cell disease, characterized by
high hemoglobin F levels (in the range of 15-25%) is common in
Kuwait.

Studies have shown that selective regulation

after gene

expression of the two copies of the y globin gene is one factor
involved in controlling HbF persistence into adult life.
globin genes of the (3

The Ay and Gy

globin gene cluster are identical except at

position 136 where either alanine (Ay) or glycine (Gy) is present.

At

birth, when HbF levels are relatively high, the Gy: Ay ratio is 7:3.

As

development proceeds,

HbF

levels decline sharply

and

the

ratio

changes to the adult value of 2:3.
In this study, we analyzed blood
families

(totalling

various

sickle

preparations

25

cell

were

samples)

and

syndromes.

6

samples from
unrelated

Hemoglobin

electrophoresed

on

12.5%

7 pedigree

individuals

lysates

and

with

globin

polyacrylamide

gels

with 6M urea, 2% Triton X-100 in 5% acetic acid, to separate the [3,a,
Ay and Gy globin chains for analysis.

HbF levels were determined

using alkali depaturation.
Our results revealed an equal proportion of Gy and Ay globin
chains and high HbF levels (ranging from 10.4%-60.7% in sickle cell
patients), suggestive of a type of heterocellular persistence of fetal
hemoglobin.
patients

However, neither Saudi Arabian or Kuwaiti sickle cell

exhibit

classical

deletion

or

nondeletion

parents of affected individuals did not have high HbF.

HPFH,

since
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I. GENETIC BASIS OF SICKLE CELL DISEASE

Sickle

hemoglobin

,HbS,

is

formed

due

to

a

simple

point

mutation in DNA in which thymine replaces an adenine residue in the
sixth codon of exon 1 of the (3 globin

gene.

During

subsequent

protein synthesis that leads to the production of the (3-globin

chain,

valine substitutes for glutamic acid in the sixth position.
Sickle cell anemia is a genetically inherited disease.
of

affected

individuals

have

either

the

heterozygous

Parents
carrier

condition known as sickle cell trait ,Hb AS, or are homozygous for
sickle hemoglobin ,Hb SS.
The term sickle cell disease covers a spectrum of disorders
ranging

from

disorders

the

almost

of intermediate

(3+-thalassemia, Sickle

benign
severity

carrier
(Sickle

a°-thalassemia,

state

of

sickle

(3°-thalassemia,

trait,

Sickle

Sickle a+-thalassemia)

the most severe form - the SS phenotype.

to

to

Also included in the

category of sickle cell syndromes are Hb SC disease, Hb SD disease
and Hb SO Arab disease. (16)
The increased clinical morbidity associated with these doubly
heterozygous conditions compared to that seen with sickle cell trait
is due to several factors.
1)

These factors include:

The presence of a second hemoglobin gene or mutant genes that
leads to absent or reduced amounts of normal hemoglobin A.
(i.e.

2)

Sickle (3-thalassemia.)

The presence of a mutant [3-chain that causes cellular
dehydration and therefore increased intracellular hemoglobin S
concentration,

(i.e.

Hb SC disease)

6
3)

The presence of a hemoglobin that participates in
polymerization to a greater degree
(i.e.

than hemoglobin A does.

Hb >SS and SO arab diseases) (33)

Epidemiological studies have shown that sickle cell syndromes
have

their

descendents.

highest

prevalence

However,

in

Black

Africans

and

their

the sickle gene has been found in Iran, Italy,

Greece, Israel, India, Saudi Arabia and Kuwait.
The association between the sickle mutation and at least three
separate restriction enzyme polymorphism haplotypes suggests that
its

distribution

throughout

the

world

is

the

result

of

multiple

mutational events and dissemination via various trade routes.

(13)

Geographically, the [3s gene is most concentrated in two areas
of West Central Africa.

One of these areas encompasses Nigeria and

Ghana and the other Gabon and Zaire.

It has been estimated that

in

these areas, as many as 25% of all newborns are AS heterozygotes.
In

African-Americans,

from 7-10%.
The

the frequency

of

AS

heterozygotes

ranges

(16)

sickle

in

East

Central India and in the north eastern region of Saudi Arabia

(the

Shia Oasis).
of the (3s

hemoglobin

gene

is also quite common

Historical evidence suggests that the high prevalence

gene in Saudi Arabia and

migrations out of East Africa.

India may have arisen from

African slaves were transported from

East Africa to the Persian Gulf from 200-1500 A.D.
active slave trading
century.

to

India from

East Africa

up

There was also
until

the

19th

The frequency of the [3s gene in North, South, and Central

America as well as the Caribbean is also linked to the slave trade
that originated in West Africa.

(16)
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Evidence for several

independent origins for the sickle cell

mutation enhances epistasis (i.e. the effects of linked and unlinked
genes on sickle gene expression) as demonstrated by hematological
differences between SS individuals from Benin and Senegal that have
different polymorphism

hap!otypes.(33)

polymorphic sites

been

enzymes.

deduced

with

the

use

of

restriction

These enzymes recognize short, specific sequences of DNA

for cleavage.

The presence or absence of a particular site is denoted

by a + or - sign.
to

has

A map of the various ps

various

These haplotype maps allow investigators to refer

polymorphisms

representation.

via

a

simplified

schematic

Figure 1 demonstrates these various haplotypes.

A

previous study describes the haplotype (—++-+)

in chromosomes

from

of

individuals

from

Nigeria,

the

southwest

peninsula, West Africa, Jamaica and the U.S.

the

A different haplotype

(++-++++-) not found in Africa, is seen in the eastern oases
Arabia

and

distribution
distribution

the west and
of

the

Asian

of a clinically

east coast of
(3s

haplotype

milder form

of

Arabian

India.

The

geographic

corresponds
homozygous

of Saudi

to

the

sickle cell

disease associated with high levels of fetal hemoglobin (HbF).

(51)
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II. THE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE
Under deoxygenated conditions such as those found in parts of
the venous and capillary circulation,
polymer formation.

sickle hemoglobin

undergoes

NMR studies reveal that deoxygenated sickle

cells become rigid even before they sickle and suggests that the
accumulation of polymer leads to decreased cellular deformability
and vaso-occlusion at precapillary sphincter levels.

(33)

As the sickle red blood cells course through the circulatory
system they undergo cellular dehydration and acquire a high MCHC
and

cell

experience

density.

As

potassium

"sickle" shape.

sickle

leakage,

cells

undergo

and calcium

deoxygenation
influx

and

they

achieve a

As this occurs, intracellular water is also lost in an

attempt to reestablish osmotic balance.

(33)

Several hypotheses have been formulated to explain the volume
loss seen in sickle cells.
1)

They are as follows:

The phase transition of Hb S induces a direct volume
difference between cells.

2)

Hemoglobin gelation leads to decreased osmotic pressures.

3)

Membrane stretching during sickling may lead to a disturbance
in the cation homeostatic state.

Since HbS occupies the same volume in the gel and sol phases and
the production of polymer and its effects on osmotic pressure do not
sufficiently account for the volume loss seen, the later hypothesis
involving membrane stretching appears to be the most scientifically
sound of the three theories.

(33)

In 1940, Drs. Ham and Castle proposed that a "vicious cycle of
erythrostasis" explained the clinical

nature of sickle cell disease.

9
They

hypothesized

that

the

dehydration

and

polymerization

of

hemoglobin S in sickle cells results in rheologic abnormalities that
are thought to account for the vaso-occlusion, painful crises, tissue
infarction and chronic hemolytic anemia seen in sickle cell patients.
The rheologic impairment of sickle cells is due to:
1)

Poor deformability of sickle cells.

2)

Concentration of sickle cells in blood.

3)

The increased adhesiveness of sickled cells to capillary
endothelial

4)

cells.

The effects of sickled cells on whole blood viscosity.
Although

the

theory

of

the

"vicious

cycle

of

erythrostasis"

remains to be proven scientifically, it has generally been accepted
that vaso-occlusion

is the main culprit responsible for the clinical

manifestations of sickle cell disease.(33)

III.

CLINICAL MANIFESTATIONS OF SICKLE CELL DISEASE
Individuals with sickle cell anemia are usually well at birth

and become symptomatic between six months and twelve months of
age.

By ten to twelve weeks of age, red blood cell sickling,

hemolytic anemia and increased levels of reticulocytosis becomes
apparent in sickle cell patients.

Infants with SS disease may appear

clinically well since the major hemoglobin

present at birth and for

several months after birth is HbF.

In children, the clinical

(33)

effects of sickle cell disease are usually acute and infectious in
nature.

However,

demonstrate
sickling.

chronic

adults
organ

with

sickle

related

cell

damage

disease
from

tend

to

uncontrolled

(78)

Studies designed by Scott et al., Ferguson et al., Porter et al.,
and others examined the clinical

manifestations of sickle cell

disease during the first year of life.

Generalized dactylitis (hand-

foot syndrome), infectious diseases and splenic sequestration crises
were noted as major areas of clinical difficulty.

(78)

Splenic sequestration crisis can be life threatening.

During

these episodes, children with progressive splenomegaly become
severely anemic in the presence of actual or imminent shock.

It has

been theorized that the splenic sequestration crisis involves an
accumulation of blood in the spleen. (16)
Pearson and O'Brien have found that sickle cell patients
demonstrate changes

in the

reticuloendothelial function

spleen during the first year of life.

Children with sickle cell anemia

often have splenomegaly by five to six months of age.
size

increases,

there

of the

is decreased

phagocytic

As the spleen
activity

of the

reticuloendothelial

cells

in

the

spleen,

demonstrated

by

isotopic

techniques which reveal elevated numbers of "pocked" RBCs in the
bloodstream.

This leads one to conclude that children with sickle

cell disease experience a type of functional asplenia as they mature.
In African and American sickle cell patients it is typical to find that
splenic infarction has occurred in older children (> 7 years of age)
and adults.

(78)

Children
susceptibility

with
to

sickle

cell

contracting

anemia

infectious

have

an

diseases.

increased
Immunologic

defects in the alternate complement pathway of sickle cell anemia
patients leads to slow chemotaxis and inefficient phagocytosis by
polymorphonuclear

leukocytes.

These

functional

exhibited

patients with

most

asplenia

likely

account

for

processes in this group.
with

sickle

cell

by

the
(78)

anemia

pneumococcal septicemia.

increased

factors

as

well

sickle

prevalence

as

cell
of

the

anemia

infectious

Incidents of sudden death in children
are

often

due

to

overwhelming

(78)

The sickle cell crisis is the hallmark of sickle cell disease and
is characterized by excruciating pain in the back, extremities, chest
and/or abdomen.
unclear;

however

Events that provoke painful crises still
these

crises

are

often

dehydration, physical or emotional stress.

preceded

by

remain

infection,

(94)

The hemolytic anemia caused by Hb SS is usually moderate and
often is overestimated due to plasma volume expansion.

The anemia

in and of itself is not a significant determinant of disease severity.
The subsequent marrow expansion, hyperplasia of erythroid marrow
and

increased

turnover

of

bile

pigments

(and

its

clinical

consequences of cholelithiasis)
types of hemolytic anemias.

are problems encountered

in

all

With proper medical management these

conditions can be compatible with a fairly normal, comfortable, long
life.

The

subsequent

vaso-occlusive
damage

to

effects

vital

of

organs

sickle
plays

cell
the

anemia
major

role

and
in

determining the degree of morbidity and mortality associated with
the disease.

(94)

The acute chest syndrome which presents with intense onset
of fever, leukocytosis, pain

on inspiration and expiration, dyspnea

and cough

is a common cause of hospitalization

patients.

Methods

to

accurately

distinguish

in

sickle cell

between

micro-

infarctive events and infectious processes in the pulmonary system
have yet to be developed.
Patients

with

(16)

sickle

cell

disease

may

also

experience

neurological deficits and seizures as a result of a cerebrovascular
accident.

Children with sickle cell disease also have delayed growth

and development. Adults with sickle cell anemia commonly exhibit
chronic organ damage that is most pronounced

in the spleen, heart,

lungs, kidneys, eyes and bones.
The

major

renal

complications

of

sickle

cell

disease

uremia, hyposthenuria, nephrotic syndrome, and hematuria.
Microinfarction of the renal papillae can cause
to concentrate and dilute urine.
zinc deficiency and wasting.

(10)

are
(77)

a loss of the ability

This isosthenuria in turn leads to
Such organ system failure can in

turn become life threatening.
The lifetime prognosis of patients of sickle cell disease in the
U.S. is not known.

In 1970, Scott calculated a median expected

1 3
survival of 20 years of age using data from the U.S. Bureau of Vital
Statistics.

Today, therapeutic interventions aimed at preventing

dehydration, maintaining fluid balance and halting the spread of
infections

has

not

made

it

unusual

for sickle

cell

patients

in

industrialized nations to survive into and beyond the third and fourth
decades.

(16)

IV. CLINICAL HETEROGENEITY IN THE SICKLE CELL SYNDROMES
One of the most striking features about sickle cell anemia is
the broad spectrum of clinical severity seen

in affected patients.

For example, some patients are incapacitated by recurrent episodes
of painful crises and ensuing

organ damage while other patients

with the same apparent phenotypic expression of HbS disease, have,
with

the

exception

of

their

hemolytic

inconsequential clinical sequela.

(94)

for a-thalassemia

levels

or

persistence of fetal

elevated

anemia

only

mild

and

The co-inheritance of a gene
of

hemoglobin - HPFH)

HbF

(i.e.

hereditary

have been

proposed as

factors modulating the clinical severity of sickle cell anemia.
Thalassemia is a genetic disorder that leads to a defect in the
production

of

hemoglobin.

one

or

more

This

defect

in

of

the

turn

synthesis of the affected chain.
individuals tends to

be

globin
leads

polypeptide

to

absent

chains

of

or decreased

The red blood cells of affected

hypochromic

(low

intracellular hemoglobin

concentration) and microcytic (smaller than normal).
Co-inheritance

of a gene for

HbS

and for

(3-thalassemia

sometimes results in a milder clinical course than that experienced
by

patients

with

thalassemia
uncertain.

on

the

SS

disease

phenotype.
severity

in

(16)
sickle

The
cell

effects

anemia

of

a-

remains

It has been suggested that the effects of hypochromia on

viscosity of blood or the diminution of internal viscosity of the red
blood cells as a result of decreased mean

HbS concentration are

possible means by which mild symptoms of HbSS are produced.
Alpha-thalassemia is made up of four "classic" syndromes:

(32)

1)

Alpha-thalassemia-2-trait is very common in Blacks, (with a
frequency of 15-20% in some populations).

In this condition,

all four a globin gene loci fail to operate correctly.
2)

Alpha-thalassemia-1-trait is a condition in which there are
two dysfunctional gene loci.

3)

In HbH disease three dysfunctional a globin gene loci are
present.

4)

In Hb Bart's, hydrops fetalis is often seen, as a result of a
defect in all four alpha globin gene loci.
Although

the

above

syndromes

are

classically

deletion of one, two, three or all four of the a globin
deletion forms of a-thalassemia also occur.

caused
genes,

by
non¬

(10)

The effect of a-thalassemia on disease severity of sickle cell
anemia remains unproven.

One study performed by Dr. Mears and his

colleagues provided for the analysis of the alpha gene deletions by
restriction endonuclease mapping of DNA from Black Americans and
Africans.

It

was

demonstrated

that

subjects

with

sickle

cell

anemia possess chromosomes bearing a gene deletions in greater
numbers than normals or individuals with sickle

trait.

They also

concluded that a gene deletions that cause a-thalassemia allow for
prolonged survival in individuals with sickle cell anemia.

Higgs et

al., were unable to demonstrate increased survival associated with
co-inheritance of HbS and a-thalassemia.

(40)

However, the investigators note that it is not clear if the co¬
inheritance of sickle cell anemia and a-thalassemia trait leads to a
milder clinical course
individuals.

(56)

(fewer and less severe crises) in affected

1 6
In

hereditary

morphologically

persistence

normal

red

of

blood

fetal
cells

heterozygous for the causative mutation
as 20-30%.

hemoglobin
in

individuals

who

are

can have HbF levels as high

Individuals who are homozygous for HPFH can produce up

to 100% HbF.

In 1961, Jackson et al. evaluated sixty-one patients

with sickle cell anemia for clinical severity.
index

(HPFH),

rating,

they

found

that

38

patients

Using a pathologic
whose

erythrocytes

contained 12% or more HbF had a significantly lower pathologic
index

rating

compared

contained little HbF.

to

23

patients

whose

red

blood

cells

They concluded that the increased amounts of

HbF protected red blood cells from sickling and thus decreased the
degree

of

severity

of

sickle

cell

anemia.

(46)

V. HEMOGLOBIN SWITCHING
The mechanism by which red blood cells switch from synthesis
of HbF to HbA during the neonatal period had been the subject of
much

study

hemoglobin

and

interest.

switching

By

occurs,

clarifying

we

may

be

the

means

able

to

by

which

elucidate

the

developmental regulation of gene expression as well as determine
means of reactivating or preventing suppression of gamma globin
gene expression.

As elevated HbF levels have been linked to milder

clinical courses in sickle cell disease and thalassemia, a potential
form of gene or pharmacological therapy may be developed based on
an understanding of hemoglobin switching.
During the last six months of gestation, fetal red blood cells
contain mostly HbF.

As the first year of life progresses, the infant's

red blood cells contain predominantly HbA.

Adult red blood cells

contain mostly HbA with small amounts of HbF and HbA2-

(92)

Figure 2 is a schematic representation of the human globin
gene clusters and an indication of when particular hemoglobin types
are produced in the course of human development.
of two gamma chains and two alpha chains.
globin genes, Gy and Ay. The Gy

HbF

is composed

There exists two y

gene encodes for glycine at position

136 and the Ay gene encodes for an alanine residue at this position.
During fetal development, the Gy to Ay ratio is 3:1 in RBCs.
hemoglobin

switch

occurs

in

the

perinatal

period

As the

leading

to

increased synthesis of HbF the Gy to Ay ratio changes from 2:3 (the
ratio seen in adult RBCs)

(92)

The exact mechanism that regulates the normal switch from y
to (3 globin gene expression remains unknown.

However, it appears

that the switch is controlled more by a developmental clock and
gestational

age than

by

intrauterine or environmental factors,

prematurity has little effect on the process. (16)
of the

process

can

occur

as

in

intrauterine

as

Some modulation
growth

retardation

(IUGR), maternal anoxia, and hyperinsulinism secondary to maternal
diabetes mellitus in which there seems to be some delay in the
switch.

Also, in some cases of Down's syndrome (Trisomy 21) and

the C/D chromosomal translocation syndrome, there appears to be an
acceleration of the hemoglobin switch.
Several

hypotheses

exist

for

(16)
the

mechanism

of

the

fetal

switch:
-Clonal model:

hemoglobin switch occurs due to a progressive

replacement of cells derived from a fetal stem cell lineage by
cells derived from an adult stem cell lineage.
-Adult vs. fetal erythroid cell expression is regulated by
changes in the degree of DNA hypomethylation and DNAase I
hypersensitivity of the 5' flanking region of DNA of both the
gamma and beta globin genes.
-Regulatory DNA sequences on the inter- y/5
be responsible for the fetal to

adult

gene

region

may

hemoglobin switch.

(16)
During fetal development, the y and p
simultaneously.
erythropoiesis

At

the

(weeks

beginning

5-20

of

of

genes are expressed
the

gestation),

liver
the

approximately fifty times more active than the p gene.
33,

p

chain

synthesis

slowly

percent of y chain synthesis.

increases

to

stage
y

gene

is

By week 30-

approximately

As the rate of y chain

of

ten

synthesis falls,

the synthesis of (3

chains

increases dramatically.

normal infant has 60-80% HbF in its RBCs.
HbF levels are approximately 3%.

At

birth,

the

By 16-20 weeks of age,

By age two years, HbF levels are

usually that of adult RBCs - < 1%.

(91)

In adults,

hemoglobin F is

found in only a subpopulation of RBCs (usually <8%) referred to as Fcells.

While F-cells appear to express other features of fetal red

blood cells, they are distinct form true fetal red cells. (102)
Various mutations have been associated with increased levels
of HbF.

In deletion mutations, there is deletion of a portion of the (3

globin gene cluster.

Non-deletion mutations reflect point mutations

within or outside of the cluster.
a

uniform

distribution
In

distribution

of

Both types of mutations can cause

HbF

(pancellular)

or

a

nonuniform

(heterocellular).

heterocellular distribution of HbF,

mutations can

increase

the percentage of F-cells and/or increase the average amount of HbF
per F-cell.

These mutations can increase Gy globin gene expression

only, Ay globin gene expression only or both.

Thalassemia mutations

can also lead to the production of hypochromic, microcytic RBCs
with

increased

HbF

production.

When

the

mutation

leads

to

morphologically normal cells associated with increased HbF levels
in

heterozygous

individuals,

the condition

is known

as hereditary

persistence of fetal hemoglobin (HPFH). (92)
Increased
episodes

of

production

of

erythropoietic

HbF can
stress

also

be

observed

during

(as

in

recovery

from

chemotherapy, bone marrow transplantation and chronic

congenital

hemolytic

results

anemias).

For

example,

acute

hemolysis

in

increased F-cell production, although required or congenital chronic

20
hemolytic anemias are rarely associated with significant elevation
in HbF levels.

Also, in severe untreated iron deficiency the F-cell

levels is within

normal

marked

increase

in

limits.

After iron

reticulocyte

replacement there is a

response which

in

turn

leads

erythroid expansion and the preferential production of F-cells.
accelerated

erythropoiesis

remains a mystery.
there

is an

leads

to

increased

F-cell

How

production

One theory is that during erythropoietic stress

increased chance of premature commitment of early

erythrocyte

progenitors which

production.

(92)

can

lead

to

an

increase

in

F-cell

In support of this idea is the observation that

acutely anemic baboons F-reticulocyte levels are low.
days the F-reticulocyte levels increase.
chronically

to

anemic

the

proportion

despite persistent reticulocytosis.

in

After a few

When the baboon becomes
of

F-reticulocytes

decrease

This is thought to occur due to

the expansion of the erythron which allows reticulocytosis to occur
with

less

disruption

of

erythropoiesis

probability of increased F-cell formation.

and

subsequently

less

(92)

Demonstrated stimulation of HbF synthesis in vitro using bone
marrow cultures from adults by

Papayannopoulou

et al.

indicates

that the HbF to HbA switch is reversible and that induction of fetal
hemoglobin synthesis in the adult is possible.
and

immunofluorescent

labeling

these

By using antibodies

investigators

gather evidence for a cellular restriction of HbF.

were

able

to

In a given HbF

colony, all the cells reacted to fluorescent antibody with the same
degree

of

intensity

regardless

of

colony

size.

It

thus

seems

probable that all the cells were programmed to have similar levels
of y chain formation.

This suggests that the signal for turning on y

chain synthesis is present on the original stem cells from which
colonies are derived.

(68)

The premise that y gene expression is dependent on erythroid
stem

cell

differentiation

and

is characteristic of

early

erythroid

cells was further supported by a study by TH. Papayannopoulou et al.
in

which

erythroid

colonies

derived

from

primitive

erythroid

precursors demonstrated consistent activation of HbF synthesis.

It

appears that this property is lost when erythroid precursors of the
adult further differentiate in vivo.
use

of

erythroid

accessible

model

expression.

(70)

These findings suggest that the

progenitor cells
for

studying

may

the

provide

regulation

a

useful,

early

of

globin

gene
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VI. SICKLE CELL DISEASE IN SAUDI ARABIA
Dr. H. Lehman and associates were the first to describe the
high

prevalence of the

sickle cell gene

in

Saudi

Arabia.

Their

analysis of more than 1000 blood samples from employees of the
Arab-American Oil Company (ARAMCO) in Danman revealed that 1025% of the people residing in the eastern province of Saudi Arabia
had sickle cell trait.

(53)

Sickle cell disease in the eastern province of Saudi Arabia is
characterized by a relatively mild clinical course which appears to
be due to the elevated HbF levels seen in this population.

It has been

suggested that this group of patients with mild sickle cell disease
may serve as a model for understanding what clinical sequela may be
ameliorated via manipulation of HbF production after birth.
In 1979, Perrine et al. described the presence of mean HbF
levels of 22-26% in Saudi Arabian children and adults.

They also

demonstrated the presence of higher levels of HbF during the first
few years of life in these patients.
of 32%, even after the age of

They found a mean level of HbF
three.

In contrast, in most other

sickle cell populations, HbF levels fall more slowly after birth than
normally but tends to be less than 15% by age one and less than 9%
by

age

three.

studied

along

Forty-two
with

specific for sickle
crises

were

rare

patients with

matched
cell

and

controls,

disease.
generally

suffered from hand-foot syndrome.

sickle
for

cell

disease were

clinical

complications

They found that vaso-occlusive
slight

in

nature.

Two

patients

Hypoplastic crises in one patient

were severe enough to warrant blood transfusions.

There was no
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were severe enough to warrant blood transfusions.
case of acute splenic sequestration crisis.
osteomyelitis

There was no

One

and one had salmonella septicemia.

patient had

Fourteen of the

42 patients with sickle cell disease were hospitalized during the
first three years of life compared to 6 of the controls.
common causes of

The most

hospitalization in the sickle cell patients were

respiratory infections and gastroenteritis.

Clinical assessment of

growth and development were within normal ranges and did not show
significant differences from controls.
reported.
months.

There were two deaths

One child died apparently from septicemia at age 25
Another child died at age 35 months from what probably

was gastroenteritis.

(75)

Of interest is the apparent preservation of splenic function in
Saudi Arabian children with sickle cell disease.

The presence of

Howell-Jolly bodies is thought to be a reliable indicator of loss of
splenic function.

Only one-sixth of Saudi infants with HbSS had

Howell-Jolly bodies when studied at 18 months and older (mean age
of 44 months).

After age one, patients of African descent with HbSS

were reported to have lost their splenic function in
four-fifths of cases.

(75)

two-thirds to

This fact may help explain the difference

in mortality rates during the first two years of life: reported as 13%
for

Jamaicans

disease.

and zero for the Saudi Arabians with sickle cell

(75)

Saudi Arabians with HbSS are 34 times more likely to get
pneumococcal meningitis, and 8 times more likely to get bacterial
meningitis than the general population.

However,

Blacks in Miami

with HbSS

have a relative risk of 309 for all bacterial meningitis

and 579 for pneumococcal meningitis.

(74)

When the mortality rates of 216 Saudi Arabs was compared
with that of 207 Chicago Blacks they were found to be 0.9% in eight
years

and

9.1%

in

five

years

respectively.

Sickling

related

complications occurred less often than seen in comparable groups of
Blacks with HbSS from the U.S.

or Caribbean.

For example, none of

the Saudi Arabians studied by Perrine and his associates in 1978 had
a history of leg ulcers while 44% of the American or Jamaican
Blacks did.

Eight percent of the Blacks age 10-19 had femoral head

necrosis compared to 4.4% of the Saudi Arabians in the same age
group.

Six

meningitis

percent of

and

10%

Blacks

had

a

had a

history of pneumococcal

history of bacterial

meningitis.

In

contrast, 1.5% of Saudi Arabs had pneumococcal meningitis and 2.6%
had bacterial meningitis.

(74)

As in American, African and Caribbean Blacks, a wide spectrum
of clinical
disease.
milder.

severity

is

seen

in

Saudi

Arabians with

sickle

cell

However, the overall clinical course of the disease is
Death was found to be rare in early childhood.

The few

deaths that have occurred in adolescents and adults from infectious
causes may reflect slower pathological damage to vital organs;
especially delayed splenic atrophy.
into

adult life - a factor which may or may not be influencing

susceptibility to infection.
M.A.F
SS

Many patients have splenomegaly

found

(74)

El-Hazmi et al. in
that

some

patients

their study of Saudi Arabians with Hb
with

low

HbF

levels

have

mild

symptoms, while others with high HbF have more severe clinical
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manifestations, indicating that some other factors are involved in
ameliorating sickle cell disease in Saudi Arabians.

(32)

Karim Kamel studied 11 patients with homozygous sickle cell
anemia who were non-Sheeah Arabs from the south eastern coast of
the Arabian peninsula and discovered that they had elevated HbF
levels ranging from 8-18%, with a mean of 11.9%.

However, he found

no significant correlation between a patient's HbF level and the
patient's clinical manifestations.

He proposes that intermixing of

the African sickle gene in this population is a possible explanation
for the clinical diversity observed.

(47)

El-Hazmi also studied sickle cell disease in Arabia and found
elevated levels of HbF.

The HbF was unevenly distributed among red

blood cells (heterocellular distribution).

He proposed that acquired

anemias such as iron deficiency or pernicious anemias may lead to
low hemoglobin concentrations that produce a new steady state in
which there are less frequent painful crises occurring.

(30)

Thus,

genetic and acquired conditions may allow for the clinical diversity
seen in sickle cell disease.
An examination of 53 children from the Saudi-Arabian south
western
revealed
marked

province
some
variation

with

sickle

interesting
from

cell

disease

findings.

1.0%

to

25%

by

El-Hazmi

HbF distribution
with

a

mean

et

al.

revealed
of

10%.

Hematological parameters did not show any statistically significant
differences between subgroups with low HbF (less than 5%, 5-10%)
and high (greater than 10%) HbF.

This suggests that the HbF level is

not the only factor influencing hematological parameters in patients
with sickle cell disease from the south western province of Saudi
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Arabia.

Patients also demonstrated a high

frequency of co¬

inheritance of alpha and beta-thalassemia, and G-6PD deficiency.

It

was found that total hemoglobin, RBC count and PCV had a higher
mean value in sickle cell patients with alpha or beta thalassemia
compared to those without thalassemia.

Red cell indices (MCV,

MCHC, MCH) were significantly lower in sickle-thalassemia patients
but

fetal

hemoglobin

significance.
Clinical

levels

did

not

show

any

statistical

(31)
manifestations of sickle cell disease

western province of

the

Saudi Arabia were found to be severe.

the children were anemic.
of these 43.9%

in

south
All of

85.4% had received blood transfusions and

had several blood transfusions.

Seventy-eight

percent demonstrated splenomegaly and 65.8% had hepatomegaly.
One patient had undergone splenectomy.

(31)

A new finding in sickle cell disease patients in Saudi Arabia
was the presence of hand-foot syndrome in 34.1% of the children
studied from the south-western

province.

Vaso-occlusive crises

were fairly common, occurring in 75.6% of those studied.

Hemolytic

crises were seen in 19.5% and infective crises in 9.7% of those
studied.

Interestingly, the presence of high HbF levels, alpha or beta

thalassemia or G-6PD deficiency did not appear to ameliorate the
clinical manifestations of sickle cell disease in the same way they
appear to in the sickle cell population in the eastern province;
although co-inheritance of alpha or beta thalassemia did improve
hematological parameters.

(31)
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The presence of a clinically severe form of sickle cell disease
in the Saudis that resembles the clinical course in Black Africans
and Americans suggests the presence of a different sickle gene in
these patients or the possibility that genetic and/or environmental
factors that help produce a mild sickle cell disease in the eastern
province are absent in the south western province of Saudi Arabia.
(31)
Red blood cells in patients with sickle cell disease, that have
increased amounts of HbF tend to have increase survival rates.

It

has been suggested that the lower levels of HbF (usually 5-10%) that
occurs in

Blacks with

HbSS is probably due to the differential

survival of cells with HbF, rather than an actual increase in HbF
synthesis.

(74)

Nonetheless, attempts to draw connections between clinical
severity and HbF levels have led to ambiguous results because it is
difficult to objectively define clinical

severity and other genetic,

environmental and physiological factors affecting clinical status .
Wood et al., studied HbF synthesis in Saudi Arabian and African
sickle cell patients

in an attempt to determine if the increased

level of HbF seen in the former group was due to the selective
survival of cells with HbF or a true increase in y chain production.
Experiments conducted in vitro and in vivo have shown that
cells containing HbF have a longer survival in the circulation than
cells without HbF.

This is thought to be due to the inhibitory effect

that HbF has on the sickling process of HbS molecules leading to a
reduction in the number of red blood cells that become irreversibly
sickled cells.

(16)
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Using single cell immunodiffusion,
significant correlation

Dover et al.

between the amount

number of F-cells.

found no

of HbF/F-cell and the

Thus, the amount of HbF/F-cell may be an

independent variable which also contributes to the overall levels of
HbF.

(28)

Later studies revealed that the synthesis of y

chains was

considerably lower than the levels of HbF in African and Saudi
Arabian

cases;

suggesting

an

increased

role

for the

survival of F-cells in sustaining increased HbF levels.
In 1987,

M.A.F.

selective

(102)

El-Hazmi and associates studied 285 males

and 432 females from Al-Hafout, Al-Qateef and neighboring villages
in the eastern province of Saudi Arabia.
studied

there

syndrome.

were

no

cases

of

leg

In the 55 SS homozygotes
ulceration,

or

hand-foot

Abdominal pain and pain in the bones and joints appeared

to be one common complaint.

Almost 70% of the SS patients had

received blood transfusions although actual sickle cell crises were
noted as being "rare."

Fifty-six percent had anemia, 36% had

hepatomegaly, 45% had splenomegaly and osteomyelitis was seen in
45% of the cases studied.

The data for the individuals homozygous

for the

revealed

sickle

cell

hematological data;

gene

variation

in

the clinical

and

some individuals exhibited chronic anemia and

others almost normal values for Hb, RBC and PCV.

Co-inheritance of

a-thalassemia has been suggested as a possible modifier of the
clinical

sequela

of

sickle

cell

disease.

The

theory

is

that

hypochromia may cause a decrease in viscosity of blood or in the
internal viscosity of the red cell due to decreased mean cell Hb SS
concentration and subsequently resulting in decreased intravascular
sickling and mild symptoms.

(32)

Pembrey et al.
109

measured HbF levels in 137 normal individuals,

sickle trait individuals

sickle cell disease.

and 237 individuals

homozygous

for

The HbF found had a heterocellular distribution.

(73)
Using the premise that

the level of HbF in the peripheral blood

is a result of the rate of HbF synthesis and differential destruction
of F-cells and non F-cells,

investigators sought to evaluate the

roles of coexistent a-thalassemia
increasing HbF levels.

and/or

G-6PD

deficiency

in

If the high levels of HbF in Saudi Arabs with

sickle cell disease was due largely to the concentration of F-cells in
the

peripheral

blood

there

would

exist

a

positive

between the rate of hemolysis and HbF level.
shown

-

an

inverse

reticulocyte count.
be

correlation

Thus,

primarily due to

between

correlation

The opposite was

HbF

level

and

the

the increased level of HbF was thought to

increased

synthesis of

HbF which

decreased hemolysis by inhibiting cell sickling.
and G-6PD deficiency were also shown to
promoting high levels of HbF

in

turn

Alpha-thalassemia

have little effect on

(73)

The heterocellular distribution of HbF and low levels of HbF
found in normal (AA)

individuals and individuals with sickle cell

trait (AS) excludes the pancellular, Negro and Greek forms of HPFH
as possible explanations for the increased levels of HbF seen in
Saudi Arabians with sickle cell disease.

Population surveys have

revealed little difference in HbF levels in normal and sickle trait
individuals of Arabian or African descent.

Low levels of HbF in

normal and AS individuals excludes the possibility of a co-dominant
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heterocellular HPFH gene in linkage disequilibrium with the sickle
gene.

(73)
Another possibility is that there is present a truly recessive

HPFH gene which is in linkage disequilibrium with the sickle gene.
This hypothesis would prove to be true if individuals from the Saudi
Arabian oasis population with sickle p°-thalassemia
high levels of HbF.
Using
produced

a
in

have similar

(72)

radioimmunoassay to
vitro

by

erythroid

assess the

amount of

progenitor-derived

HbF

erythroblasts,

investigators have sought to determine the basis of increased HbF.
Results of this

study

revealed that

HbF synthesis

is

a

major

contributor to increased HbF levels in Saudi Arabians with sickle
cell anemia.
inherited
increased

The findings also suggest that the high HbF levels are

from

at

least one

erythropoiesis.

parent but

The

Saudi

its

expression

Arabian

requires

patients

consistently had an increased ratio of Gy to Ayglobin.

studied

In contrast,

80% of Black Americans with sickle cell disease have 40% Gy and
60% Ay with only 20% having more Gy than Ay. (59)
Interestingly,

Miller and her colleagues found that patients

homozygous or heterozygous for the ++-++ haplotype and with the SS
phenotype have an increased level of HbF synthesis.

However,

homozygosity for the ++-++ haplotype in and of itself did not appear
to control HbF levels.

Individuals heterozygous for the sickle gene

and homozygous for ++-++ had only modest elevations in HbF.

(58)

Miller proposes that the amount of HbF produced depends on
erythropoietic stress, the degree of maturation of the progenitor
cells and the "permissiveness" of the yglobin gene.

In

a follow-up

study,

Miller

studied

55

members

of five

families with sickle cell disease to determine if the specific yp gene
cluster seen in these individuals could explain the increased HbF
levels,

increased

Gy/Ay ratio

progenitor derived erythroblasts.

and elevated

HbF production

by

Starting with the knowledge that

most Saudis with sickle cell anemia were

homozygous for the

haplotype ++-++++- characterizing the p globin gene cluster, the y
globin

gene

region

was

isolated

via

molecular

nucleotide substitution C-> T at position -158
was

recognized

using

restriction

cloning.

The

5' to the Gy cap site

endonucleases.

The

results

revealed that Saudis homozygous or heterozygous for the sickle gene
with a -158 C->T substitution, even on one chromosome, had an
elevated level of Gy >

50%.

No significant differences were found

between heterozygotes or homozygotes with the C->T substitution
on one or both chromosomes.
Gy

This suggests that while an increase in

globin may be associated with the C->T substitution it does not

necessarily produce a measurable increase in total HbF production.
(58)
Miller also found that Saudis with one copy of the "common"
eastern oasis haplotype +++-S do not have elevated total circulating
HbF (in contrast to their African and Mediterranean counterparts)
but did demonstrate variable increases in the Gy /Ay ratio ratio.

The

authors confirmed their previous finding that the presence of the
+++-S

yp

haplotype on both chromosomes correlated with the

extent of HbF production in Saudis.
suggest a tight linkage.

This association does not

The authors hypothesize that the

-158 C->T
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substitution may increase the ability of the Gy
transacting proteins.

region to respond to

The actual amount of the HbF produced in red

blood cells may be dependent upon the intracellular level of these
transacting proteins and cm the specific DNA sequences near and/or
far away from the yglobin genes.
affect

the

increased

transacting
expression

regulatory
of

Also, erythropoietic stress may
protein

levels

and

Gy genes and total HbF.

lead
(58)

to
The

identification of the regulatory proteins controlling globin gene
expression and description of their function will help to clarify
factors responsible for the HbF levels in Saudi Arabians and others
with sickle cell anemia.
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VII.

SICKLE CELL DISEASE IN KUWAIT
The high frequency of the sickle gene in the region bordering

the western coast of the Arabian gulf appears to be due to three
factors:
1)

Falciparum malaria was endemic in this area into the
mid-20th century, allowing for a selective survival
advantage to heterozygotes.

2)

Homozygous disease appears to be compatible with
survival into adult life and reproduction.

3)

A high rate of consanguinity exists with frequent first
cousin marriages). (71)

Of the Kuwaiti patients studied by Pearson et al.,

47 were

found to have Hb SS disease while 21 had Hb Sp-thalassemia.

No

significant

SS

patients

difference

and

hemoglobin

the

level,

was

Hb

found

between

Sp-thalassemia

the

patients

Kuwaiti
in

Hb

regards

reticulocyte count, and percent HbF.

to

This is

similar to the situation seen in the U.S., where Sp-thalassemia

and

SS patients have similar clinical and hematological pictures. (71)
Kuwaiti

sickle cell

patients were compared

with

American

sickle cell patients and the former group was found to have higher
levels of

HbF than

significantly

the

higher and

Kuwaiti patients.

(71)

latter group.

Hemoglobin

levels were

reticulocyte counts significantly

lower in

Hemoglobin levels in the Kuwaiti sickle cell

disease patients ranged from 70-120 g/L.

None of their American

counterparts had hemoglobin levels above 90 g/L or HbF levels over
10%. (71)
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Kleinhauer-Betke preparations were done on six Hb SS and four
Hb

Sp-thalassemia

Kuwaiti

patients

and

all

revealed

a

heterogeneous distribution of HbF in their erythrocytes; a finding
similar to that seen in Saudi Arabians with sickle cell disease.

(71)

Analysis of clinical records of Kuwaiti patients by Pearson et
al., revealed a relatively mild clinical course for most.

Only 10% had

experienced sickle cell dactylitis (hand-foot syndrome)
one-third of the American cases.

compared to

Painful crises appeared to be

more responsive to analgesia and IV hydration than American cases.
There were no new episodes of splenic sequestration syndrome and
only

one

episode

of

stroke

and

two

episodes

of

Salmonella

osteomyelitis at the Sabah Children's Hospital between 1976-1985.
(71)
Eighteen of 21 patients with Sp-thalassemia and 13 out of 47
with SS disease had splenomegaly.
had palpable splenomegaly.

No American sickle cell patients

Thirty-five percent of Kuwaiti patients

with Sp-thalassemia had weights <

10th

percentile and 75% of

Kuwaiti HbSS patients had weights at this level.
group, 35% showed this degree of growth delay.
During
patient died.

the years

1976-1983,

only one

In the American

(71)
Kuwaiti

sickle cell

This death was determined to be due to causes

unrelated to sickle cell disease.

There were no recognized causes of

overwhelming sepsis, which is seen in 10-20% of patients in the U.S.
The lack of severe infectious complications in Kuwaiti sickle cell
patients may be due to the overall preservation of splenic function.
(71)

Pearson et al., evaluated this premise by analyzing the amount
of pocked RBCs found in Kuwaiti versus American sickle cell disease
patients.

Preservation of splenic function associated with a low

percentage of pocked RBCs in sickle cell patients from the eastern
province of Saudi Arabia has been reported.

Pearson et al., found

that in 10 Kuwaiti patients with HbF levels > 15% and concomitant
Hb SS or Hb Sp-thalassemia, all had normal splenic function.

Of

note, all the American cases had >10% pocked RBCs indicating
functional hyposplenism. (71)
A third of patients with a hemoglobin SF electrophoretic
pattern (21/68) were shown by family studies to have the Sf%
thalassemia genotype.
also be prevalent in

It appears that the a-thalassemia gene may
Kuwait as some of the

individuals with

homozygous sickle cell disease had microcytosis. (71)
American

sickle cell

patients

have

a greater degree

of

hemolysis than their Kuwaiti counterparts as demonstrated by their
lower mean hemoglobin levels and higher reticulocyte counts.
occlusive events are less frequent and less severe in

VasoKuwaiti

patients, which may be due to the higher levels of HbF seen in this
group.

Most of the Kuwaiti patients with Hb SS and Hb Sb-

thalassemia have HbF levels between 10-20% into adolescence.
contrast, American cases of Hb SS and Sp-thalassemia
display HbF levels > 10% after ten years of age. (71)

In

rarely
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However, sickle cell disease in Kuwait is not "benign."

Several

Kuwaiti patients with low levels of HbF (2-6%), had frequent painful
crises, requiring hospitalization and frequent blood transfusions.
Also,

longitudinal studies on a larger population of sickle cell

patients in Kuwait may reveal complications which may only be
apparent in older patients. (71)

VIII.

MECHANISMS MODULATING FETAL HEMOGLOBIN LEVELS
Studies

lend

support to

the

hypothesis that

at

least three

variables contribute to high HbF levels:
(1)

The percentage of RBCs and

reticulocytes containing HBF.

(2)

The quantity of HbF synthesized within F-cells.

(3)

The extent to which preferential F-cell survival increases HbF
levels. (28)
Dover

regulated

et al., concluded that these variables are independently

and

that

different between
the

production

the

expression

individual

of

HbF

heterocellular HPFH

as

each

patients.

may
in

of

its

be

variable

They also

as

great

presence.

in

is

distinctly

determined that
the

absence

While the

of

investigators

agreed that HbF offered RBCs protection against premature loss, the
degree

to

which

it

individual to another.

does

so

was

felt

to

be

variable

from

one

The inherent implication of this is that there

exists a factor (or factors) other than HbF levels that modifies Fcell production and survival.

(28)

An analysis of in vivo changes in
the hypothesis that increased
accelerated erythropoiesis.

F-cell production supports

F-cell production

is associated with

F-cell production in a child with sickle

cell anemia was found to be reduced to a greater degree than non-Fcell

production

when

erythropoiesis

is

suppressed.

support to the idea that F-cell production
from non-F-cell production.

This

lends

is regulated separately

It is not clear if falling erythropoietin

levels and subsequent depressed erythropoiesis are associated with
selective

depression

conclude

that

of

individuals

F-cell
with

production.
sickle

cell

(29)
anemia

The
like

authors

individuals
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with normal hemoglobin, can change their relative F-cell production
in response to erythropoietic stress via a process that is under a
different system of regulation than non-F-cells.
By examining y globin gene
with

elevated

(29)

expression, haplotypes associated

FlbF levels and the clinical course of sickle cell

patients with high FlbF, it is hoped that the mechanisms regulating
HbF synthesis will be clarified.

In the Saudi Arabian population, a

milder form of sickle cell disease is found that is associated with
high HbF levels.

A

similar syndrome can also be seen in Asian-

Indians with sickle cell disease.

Interestingly, unlike Jamaican or

American Blacks with sickle cell disease and high hemoglobin F
levels, one usually cannot identify in Saudi or Indian families a
parent with

slight elevation

of HbF - a finding

that would

consistent with the Swiss type of heterocellular HPFH.
In

Swiss

type

be

(16)

HPFH, an autosomal dominant inheritance

pattern leads to slightly elevated HbF levels usually in the range of
2-3% in heterozygotes.

The HbF produced has both Gy and Ay

subtypes of the y globin chains.

Individuals with Swiss type HPFH

and a hemoglobinopathy are often asymptomatic.
defect in Swiss type HPFH is unknown.

The molecular

(16)

F-cell production in sickle cell anemia may be regulated by a
genetic locus that is linked to or separate from the (3 globin gene
cluster.

Attempts

to

elucidate

mechanisms

modifying

F-cell

production are compounded by the preferential survival of F-cells
that varies from individual to individual and thus serves as a poor
indicator of actual levels of F-cell production. (24)

Dover et al.

correlated F-reticulocyte levels in sibling pairs with SS disease and

between parents and their children and found that genes controlling
F-cell levels are linked to the p globin

gene site and that these

genes also control F-cell production in non-anemic individuals.

(24)

Boyer et al., in a later study, again looked at F-cell production
in an attempt to determine if it is regulated by a site (or sites)
separate

from

the

p

globin gene cluster.

Results

revealed a

substantial number of sibling pairs with discordant F-reticulocyte
levels.

The

reproducible.

discordance

was

found

to

be

significant

and

Polymorphic markers were used to ascertain that the

discordance appeared in siblings who almost certainly had the same
mother and father. (12)
genetic

regulator

of

Boyer et al., concluded that at least
F-cell

production

in

sickle

cell

one

anemia

segregated separately from sickle hemoglobin.

A gene separate from

the p

F-cell

globin

gene

cluster

may

regulate

elaborating or modifying a substance that
or effector site on the p globin gene

production

by

interacts with a receptor

region.

Mutations

in

the

modifying substance or gene site itself could then control levels of
F-cell production.
Another

hypothesis,

supported

by

the

finding

that

HbF

synthesis in vivo is usually completed early in erythroid maturation,
is that a gene (or genes) can control HbF levels by influencing the
percentage of cells in various stages of development when the F-cell
"window" is open.

(12)

The finding that 5-azacytidine increases F-reticulocytes from
10% to as much as 52% in sickle cell anemia patients has caused
cautious optimism that new therapeutic modalities for sickle cell
disease may be on the horizon.

The rise in F-reticulocyte levels
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from

the

use

of

5-azacytidine

has

been

demethylation v of DNA associated with y
marrow erythroid cells.

associated

with

a

globin genes from bone

The persistence of fetal

hemoglobin in

childhood and adulthood may be due to mutations in the y globin gene
associated

DNA

which

inhibit

methylation

later

in

life.

(62)

IX.

EXPERIMENTAL OBJECTIVES
The purpose of our study was to examine the levels of HbF in

patients

with

Furthermore,
patients

sickle
an

was

cell

disease

analysis of

undertaken

7

in

in

the

Kuwaiti

population.

globin gene expression

an

attempt

to

facilitate

understanding of the mechanisms involved in

in

these

scientific

increasing

7

chain

synthesis.

X.

METHODS AND MATERIALS

Solutions & Buffers
Solution A:

10% Ammonium Persulfate (fresh)

Solution B:

60% Acrylamide + 0.4% Bis (stored at 4° C; redissolved
in a 37°C water bath)

Solution C:

10% Triton X-100

Solution D:

(Loading Buffer):

6M

Urea +

8%

HAC +

8%

(3-

mercaptoethanol + 0.3 mg/ml pyronine Y
1 M Cysteamine
Lysis Buffer:

5mM MgCl2 (stored at 4°C)

Coomassie Blue Stain Solution:

.62 g Coomassie Blue in 10% acetic

acid and 45% methanol solution
Destain Solution:

10% acetic acid and 10% methanol solution

Acid Acetone:

2 ml 12N HCI + 38 ml acetone + 3001

b-

mercaptoethanol

Hemoglobin
Blood

Purification
samples

from

seven

pedigree

individuals with various forms of sickle cell

families

and

eight

and/or thalassemia

42
syndrome

(including

SF,

Sickle

(3-thalassemia, (3-thalassemia

intermedia) were collected via venipuncture at Al-Sabah Children's
Hospital

in

Kuwait.

HbF

levels

were

determined

by

alkali

denaturation.
Erythrocytes from peripheral blood of patients was washed
three times in an equal volume of phosphate buffered saline (PBS).
Between each washing the sample was centrifuged at 2000 rpm for
five minutes in a RC-2 Sorvall refrigerated centrifuge.
layer was carefully removed with a Pasteur pipette.
was then solubilized at 4° C for 10 minutes in
buffer.
4

The serum
The sample

four volumes of lysis

The sample was then centrifuged at 10,000 rpm (using a HB-

rotor) for 20 minutes.

The liquid layer containing hemoglobin was

removed with a Pasteur pipette (without disturbing the layer of
cellular debris at the bottom of the tube), placed in labelled tubes
and stored at -70° C.
Some of our blood samples had
transit from Kuwait.
using acid acetone.
to our sample.

lysed prematurely during

From these samples globin preps were made
Acid acetone at 4° C was added in a 1:20 volume

The mixture was centrifuged in a RC-2 Sorvall

centrifuge for five minutes at 10,000 rpm.

The liquid supernatent

layer was discarded and the pellet was washed three times with
plain acetone at 4° C.

The pellet was then dried using nitrogen gas.

The pellet was resuspended in 500 microliters of loading buffer
(Solution D), placed in an appropriately labelled tube and stored at 70° C.

Triton Gel Electrophoresis
A 12.5% polyacryalmide gel with 6M urea, 2% Triton X-100 in
5% acetic acid was used to separate the globin chains, using a
procedure previously described by Rovera et al. (84)
The gel was prepared by combining 2 ml of solution B + 0.5 ml
glacial acetic acid + 25CRTEMED (N.N.N'.N', - tetramethylenediamine)
+ 18 grams

urea and distilled water to bring the volume up to 49 ml.

The solution was vortexed and degassed under a vacuum.
hundred microliters of solution A and 1

Three

ml of 100% Triton were

added to the gel solution.

The gel was then poured between two

glass plates with spacers.

It was overlaid with distilled water and

allowed

to

polymerize.

spacer was removed

After

polymerization

occurred

the

top

and the gel was overlaid with distilled water.

The gel was pre-electrophoresed for one hour at 200 V with 5%
acetic acid running buffer.

The buffer was then removed and the gel

was overlaid with 1M cysteamine (10 microliters per well).

The

reservoir was

and

refilled

with

5%

acetic

acid

running

buffer

electrophoresed for 45 minutes at 140 V.

Buffer was again removed

and

microliters

hemoglobin

microliters

samples

of solution

applied

D).

samples were run as controls.

(2-5

Normal

lysate

adult and fetal

in

30

hemoglobin

The gel was electrophoresed at 60

volts for 8-16 hours with the current running backwards towards
the anode.

Gels were stained for 30 minutes with Coomassie Blue

and destained by diffusion in 10% acetic acid and 10% methanol.
Gy/Ay globin ratio was determined via visual inspection.

The
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XI. RESULTS
Familv #

Identification

Diaanosis

Unrelated
individuals

R.W. (patient)
S.A. (patient)

SF
Sickle-p0 thal

with

S.D.

(patient)

HbF

A.S.

(patient)

Family #1

M.A. (patient)
H.H. (patient)
Faiza (patient)

high

%HbF

16%
15.5%
Sickle-p0 thal
21.7%
p-thal intermedia 37.5%
10.4%
Sickle-p thal
SF
16%
homozygous
60.7%

Gy/ Ay
1:1
1:1
1:1
1:1
1:1
1:1
1:1

Sp-thal
Sickle-p0 thal

9.7%

1:1

SF
AS
AS

33%
<2%
<2%

1:1
1:1
1:1

SF
AS
AS

22%
<2%
<2%

1:1
1:1
1:1

(patient)
(patient)
(mother)
(father)

ASF
SF
AS
AS

15%

1:1
1:1
1:1
1:1

(patient)
(patient)
(patient)
(father)
(mother)

ASF
SF
SF
AS
AS

24%
24%
<2%
<2%

1:1
1:1
1:1
1:1
1:1

SF
AS
AS
AS
A?

32%
20%
<2%
<2%
<2%

1:1
1:1
1:1
1:1
1:1

Father
Family #2

M. B.
N. J.
B.O.

Family #3

A.S.
S.A.
G.B.

Family #4

W.M.
FI.M.
K.M.
M.T.

Family #5

Family #6

N.A.
S.A.
M.A.
A.I.
A.H.

(patient)
(mother)
(father)
(patient)
(father)
(mother)

A.N. (patient)
Q.N. (sibling)
H.N. (sibling)
W.H. (father)
A.A. (mother)

★

<2%
<2%

★
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Family #7

L.S. (patient)
S.J. (father)
S.M. (mother)

23%
<2%
<2%

SF
AS
AS

*— Denotes inability to accurately quantify %HbF
ASF - Electrophoresis revealed hemoglobins F, A and S
Our data revealed:
(1)

All of the Kuwaiti sickle cell disease patients

sampled,

exhibited high levels of HbF, ranging from 10.4-60.7%
(2)

The expression of each of the gamma globin genes, Gy and Ay,
is equal in the Kuwaiti patients studied.

(3)

Our results were similar to those seen in the analysis of the
Gy/Ay
due

ratio in Saudi Arabians with mild sickle cell disease

to heterocellular HPFFI.

classical HPFH,

However, Kuwaitis do not exhibit

as the parents of affected individuals do not

have high HbF levels.

1:1
1:1
1:1

i
I

I

Normal Fetal

Sickle B° Thalassemia
B Thalassemia Intermedia
Sickle B Thalassemia
Sickle B° Thalassemia
Homozygous S-B°Thalassemia
Sickle B°T halassemia

RANDOM INDIVIDUALS WITH HIGH FETAL HEMOGLOBIN

Normal Adult

7

SIBLING

FAMILY

io

.'«c r

.tiifmr !r
tc

~

mouse model for

for sickle cell disease.

In a series of experiments,

the dominant control region (DCR) sequences which flank the (3 globin
gene locus,

were used to direct the copy number dependent

expression of human p globin gene in erythroid cells and
mice.

By linking

transgenic

the p globin DCR sequences to the human alpha

globin gene, high level expression can be obtained.

One of the

transgenic mice revealed no abnormal somatic development, and no
obvious evidehce of hemolytic anemia, although HbS concentration
was 83%.

It is possible that the 17% normal mouse hemoglobin

offered some protection against hemolytic anemia, just as similar
amounts of fetal hemoglobin appear to protect human ps/HPFH
heterozygotes.
disregard

the

Greaves et al.
physico-chemical

note

however that one cannot

properties

and

microcirculatory

changes that may be responsible for this clinical picture.

The future

development of an animal model for sickle cell disease could serve
to further define the factors mediating clinical severity in sickle
cell disease as well as screen potential anti-sickling agents.

This

animal model could also serve as a template for the development of
somatic gene therapy using the p globin DCR. (38)
New therapeutic options for the treatment of sickle cell
disease may also be developed and the technology of molecular
genetics improves.

With the advent of recombinant DNA technology,

molecular cloning of the human globin gene is now possible.
Nucleotide

sequences

methylation

of "key"

have

been

modified

nitrogenous bases)

(by

acetylation

or

to deliniate

elements

involved in the regulation of globin gene expression.

Use of

restriction enzymes has led to the mapping of the various sickle cell

:"!0i*0! i. -

•-
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alleles and further understanding of the interaction between sickle
hemoglobin states and alpha thalassemia.

(10)

The molecular basis for the predominance of y globin gene
expression during gestation and the subsequent switch to (3 gene
expression

just prior to

birth

remains

incompletely

understood.

However, many agree that prevention or reversal of this switch
would help to decrease the clinical severity for patients with sickle
cell anemia.

Such an intervention would decrease or suppress

expression of abnormal (3 genes and replace their gene products with
HbF, the product of y globin gene expression.
Therapeutic manipulation of y and (3 globin gene expression may
be

obtainable

acetyl

or

other

Hypomethylation
activity.

via

further clarification
moieties

on

of the

particular

effect

of

methyl,

nitrogenous

bases.

has been associated with high

levels of gene

Disimone et al. in a series of experiments showed that

treatment of baboons with

the methylation inhibitor 5-azacytidine

(a cancer chemotherapy drug) led to high levels of fetal hemoglobin
production.

The toxicity of 5-azacytidine and unknown effects of

the drug on other genes make it unsuitable for widespread clinical
use.
The

polymerase

chain

reaction

(PCR),

designed

to

enzymatically amplify selective sequences of DNA, allows for sickle
cell disease to be identified quickly and easily.

PCR and subsequent

direct DNA sequencing may allow for identification of deletions, or
mutations

associated

with

high

HbF

levels.

While

restriction

enzyme mapping is a quick and easy technique, it is limited to the
linkage analysis of polymorphic restriction sites and to situations

:£}

in which the mutation creates or disrupts a restriction site.

PCR

and subsequent DNA sequencing or analysis with allele specific
oligonucleotide probes can serve as a more general

means of

investigating possible causes of the clinical heterogeneity seen in
sickle cell disease.

(85)

In summary, we analyzed hemoglobin F levels and expression of
the y globin genes in a population of Kuwaiti patients with
sickle cell disease.

mild

While the Gy/Ay ratio of 1:1 was lower than the

fetal ratio of 7:3, it remains higher the the 2:3 ration seen in normal
adult RBCs.

Previous studies have defined an association between

high HbF levels and decreased morbidity and mortality in sickle cell
patients.

We propose that future studies should provide for the

cloning and sequencing of the y and p globin gene region and their
promoters

as

well

as

in-depth

linkage

analysis

to

delineate

molecular mechanisms that may serve to increase PlbF levels under
conditions of severe erythropoietic stress.
of HbF production

and/or clinical

Molecular determinants

heterogeneity

may be closely

linked to the p globin gene cluster, linked to the p globin

gene

cluster but outside of the region spanning the e to cppl- globin genes
or

farther

away

on

chromosome

lip

or

even

on

a

different

chromosome. (61) It is likely that such linkage analysis will serve
to clarify and accurately define on a molecular basis, a number of
"sickle cell syndromes" that currently fall under the general rubric
of sickle

cell disease.

MAJOR SICKLE p GLOBIN GENE HAPLOTYPES

£

H

Gy

Hd

Ay

<pP

5

A

1

A

Hd

H

H

A

Hp

B

Figure 1
The haplotype is characterized by the presence or absence (+ or -) of an
array of of polymorphic restriction sites within the p globin gene
cluster. (5 1)
H = Hindi I
Hd = Hindi 11
A = Aval I
Hp = Hpal
B = BamHI
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Figure
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Chart demonstrates changes in globin chain production,
hematopoeisis,

red cell morphology,

sites of

and size of erythrocytes

during prenatal and postnatal life.
(From H. Franklin Bunn and
Bernard G. Forget
Hemoglobin:
Molecular, Genetic and Clinical
Aspects.

Philadelphia:

WB Saunders,

1986)
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